Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 2
1977 2
1987 2
1989 2
1990 1
1991 4
1992 2
1993 3
1994 3
1995 2
1996 2
1997 3
1998 4
1999 2
2000 6
2001 6
2002 4
2003 3
2004 6
2005 2
2007 5
2008 10
2009 8
2010 12
2011 8
2012 14
2013 13
2014 13
2015 5
2016 9
2017 7
2018 9
2019 6
2020 3
2021 6
2022 5
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

185 results

Results by year

Filters applied: . Clear all
Page 1
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
King TE Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, Kardatzke D, Lancaster L, Lederer DJ, Nathan SD, Pereira CA, Sahn SA, Sussman R, Swigris JJ, Noble PW; ASCEND Study Group. King TE Jr, et al. N Engl J Med. 2014 May 29;370(22):2083-92. doi: 10.1056/NEJMoa1402582. Epub 2014 May 18. N Engl J Med. 2014. PMID: 24836312 Free article. Clinical Trial.
An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease.
Meyer KC, Raghu G, Baughman RP, Brown KK, Costabel U, du Bois RM, Drent M, Haslam PL, Kim DS, Nagai S, Rottoli P, Saltini C, Selman M, Strange C, Wood B; American Thoracic Society Committee on BAL in Interstitial Lung Disease. Meyer KC, et al. Am J Respir Crit Care Med. 2012 May 1;185(9):1004-14. doi: 10.1164/rccm.201202-0320ST. Am J Respir Crit Care Med. 2012. PMID: 22550210
Opportunities for mitochondrial disease gene therapy.
Viscomi C, van den Ameele J, Meyer KC, Chinnery PF. Viscomi C, et al. Among authors: meyer kc. Nat Rev Drug Discov. 2023 Jun;22(6):429-430. doi: 10.1038/d41573-023-00067-z. Nat Rev Drug Discov. 2023. PMID: 37106085 No abstract available.
Lung transplantation.
Meyer KC. Meyer KC. F1000Prime Rep. 2013 May 1;5:16. doi: 10.12703/P5-16. Print 2013. F1000Prime Rep. 2013. PMID: 23710330 Free PMC article.
Mechanisms of IRF2BPL-related disorders and identification of a potential therapeutic strategy.
Sinha Ray S, Dutta D, Dennys C, Powers S, Roussel F, Lisowski P, Glažar P, Zhang X, Biswas P, Caporale JR, Rajewsky N, Bickle M, Wein N, Bellen HJ, Likhite S, Marcogliese PC, Meyer KC. Sinha Ray S, et al. Among authors: meyer kc. Cell Rep. 2022 Dec 6;41(10):111751. doi: 10.1016/j.celrep.2022.111751. Cell Rep. 2022. PMID: 36476864 Free article.
Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis: A Randomized Clinical Trial.
Raghu G, van den Blink B, Hamblin MJ, Brown AW, Golden JA, Ho LA, Wijsenbeek MS, Vasakova M, Pesci A, Antin-Ozerkis DE, Meyer KC, Kreuter M, Santin-Janin H, Mulder GJ, Bartholmai B, Gupta R, Richeldi L. Raghu G, et al. Among authors: meyer kc. JAMA. 2018 Jun 12;319(22):2299-2307. doi: 10.1001/jama.2018.6129. JAMA. 2018. PMID: 29800034 Free PMC article. Clinical Trial.
Lung transplantation for pulmonary sarcoidosis.
Meyer KC. Meyer KC. Sarcoidosis Vasc Diffuse Lung Dis. 2019;36(2):92-107. doi: 10.36141/svdld.v36i2.7163. Epub 2019 May 1. Sarcoidosis Vasc Diffuse Lung Dis. 2019. PMID: 32476942 Free PMC article. Review.
Recent advances in lung transplantation.
Meyer KC. Meyer KC. F1000Res. 2018 Oct 23;7:F1000 Faculty Rev-1684. doi: 10.12688/f1000research.15393.1. eCollection 2018. F1000Res. 2018. PMID: 30416706 Free PMC article. Review.
185 results